Logo image of BSVN

BANK7 CORP (BSVN) Stock Fundamental Analysis

USA - NASDAQ:BSVN - US06652N1072 - Common Stock

46.61 USD
-0.92 (-1.94%)
Last: 9/29/2025, 12:19:13 PM
Fundamental Rating

4

Taking everything into account, BSVN scores 4 out of 10 in our fundamental rating. BSVN was compared to 392 industry peers in the Banks industry. BSVN has an average financial health and profitability rating. BSVN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BSVN was profitable.
In the past year BSVN had a positive cash flow from operations.
In the past 5 years BSVN has always been profitable.
BSVN had a positive operating cash flow in each of the past 5 years.
BSVN Yearly Net Income VS EBIT VS OCF VS FCFBSVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

BSVN's Return On Assets of 2.41% is amongst the best of the industry. BSVN outperforms 98.21% of its industry peers.
BSVN's Return On Equity of 19.12% is amongst the best of the industry. BSVN outperforms 97.96% of its industry peers.
Industry RankSector Rank
ROA 2.41%
ROE 19.12%
ROIC N/A
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)19.53%
ROE(5y)18.95%
ROIC(3y)N/A
ROIC(5y)N/A
BSVN Yearly ROA, ROE, ROICBSVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 46.14%, BSVN belongs to the best of the industry, outperforming 99.23% of the companies in the same industry.
In the last couple of years the Profit Margin of BSVN has grown nicely.
The Operating Margin and Gross Margin are not available for BSVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 46.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.96%
PM growth 5Y19.91%
GM growth 3YN/A
GM growth 5YN/A
BSVN Yearly Profit, Operating, Gross MarginsBSVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

BSVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BSVN has been increased compared to 1 year ago.
Compared to 5 years ago, BSVN has less shares outstanding
BSVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BSVN Yearly Shares OutstandingBSVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BSVN Yearly Total Debt VS Total AssetsBSVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BSVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC8.84%
BSVN Yearly LT Debt VS Equity VS FCFBSVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSVN Yearly Current Assets VS Current LiabilitesBSVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

BSVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.07%, which is quite impressive.
Measured over the past years, BSVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.98% on average per year.
Looking at the last year, BSVN shows a decrease in Revenue. The Revenue has decreased by -2.21% in the last year.
Measured over the past years, BSVN shows a quite strong growth in Revenue. The Revenue has been growing by 17.51% on average per year.
EPS 1Y (TTM)36.07%
EPS 3Y23.81%
EPS 5Y42.98%
EPS Q2Q%-5.69%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y20.65%
Revenue growth 5Y17.51%
Sales Q2Q%0.17%

3.2 Future

Based on estimates for the next years, BSVN will show a decrease in Earnings Per Share. The EPS will decrease by -5.48% on average per year.
BSVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.38% yearly.
EPS Next Y-8.19%
EPS Next 2Y-5.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.53%
Revenue Next 2Y1.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BSVN Yearly Revenue VS EstimatesBSVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
BSVN Yearly EPS VS EstimatesBSVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.05 indicates a reasonable valuation of BSVN.
Based on the Price/Earnings ratio, BSVN is valued cheaper than 80.36% of the companies in the same industry.
BSVN is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.78, which indicates a very decent valuation of BSVN.
The rest of the industry has a similar Price/Forward Earnings ratio as BSVN.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, BSVN is valued rather cheaply.
Industry RankSector Rank
PE 10.05
Fwd PE 10.78
BSVN Price Earnings VS Forward Price EarningsBSVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BSVN is valued a bit cheaper than the industry average as 63.01% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.6
EV/EBITDA N/A
BSVN Per share dataBSVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

BSVN's earnings are expected to decrease with -5.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2Y-5.48%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.26%, BSVN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.52, BSVN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.41, BSVN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

The dividend of BSVN is nicely growing with an annual growth rate of 73.25%!
BSVN has been paying a dividend for over 5 years, so it has already some track record.
BSVN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)73.25%
Div Incr Years4
Div Non Decr Years4
BSVN Yearly Dividends per shareBSVN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BSVN pays out 19.64% of its income as dividend. This is a sustainable payout ratio.
DP19.64%
EPS Next 2Y-5.48%
EPS Next 3YN/A
BSVN Yearly Income VS Free CF VS DividendBSVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BSVN Dividend Payout.BSVN Dividend Payout, showing the Payout Ratio.BSVN Dividend Payout.PayoutRetained Earnings

BANK7 CORP

NASDAQ:BSVN (9/29/2025, 12:19:13 PM)

46.61

-0.92 (-1.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners35.23%
Inst Owner Change0.35%
Ins Owners6.57%
Ins Owner Change0.34%
Market Cap440.46M
Analysts80
Price Target54.06 (15.98%)
Short Float %1.46%
Short Ratio2.71
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend0.87
Dividend Growth(5Y)73.25%
DP19.64%
Div Incr Years4
Div Non Decr Years4
Ex-Date09-19 2025-09-19 (0.27)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.14%
Min EPS beat(2)6.56%
Max EPS beat(2)13.73%
EPS beat(4)4
Avg EPS beat(4)9.63%
Min EPS beat(4)4.75%
Max EPS beat(4)13.73%
EPS beat(8)7
Avg EPS beat(8)10.8%
EPS beat(12)10
Avg EPS beat(12)7.98%
EPS beat(16)11
Avg EPS beat(16)5.91%
Revenue beat(2)1
Avg Revenue beat(2)1.88%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)5.54%
Revenue beat(4)3
Avg Revenue beat(4)2.29%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)5.54%
Revenue beat(8)6
Avg Revenue beat(8)4.64%
Revenue beat(12)8
Avg Revenue beat(12)3.71%
Revenue beat(16)10
Avg Revenue beat(16)2.54%
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.11%
EPS NY rev (1m)1.95%
EPS NY rev (3m)6.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.96%
Valuation
Industry RankSector Rank
PE 10.05
Fwd PE 10.78
P/S 4.58
P/FCF 10.6
P/OCF 9.39
P/B 1.9
P/tB 2
EV/EBITDA N/A
EPS(TTM)4.64
EY9.95%
EPS(NY)4.32
Fwd EY9.28%
FCF(TTM)4.4
FCFY9.43%
OCF(TTM)4.96
OCFY10.65%
SpS10.17
BVpS24.54
TBVpS23.26
PEG (NY)N/A
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 19.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.14%
GM N/A
FCFM 43.24%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)19.53%
ROE(5y)18.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.96%
PM growth 5Y19.91%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 515.48%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 93.71%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)211.77%
Cap/Depr(5y)146.78%
Cap/Sales(3y)2.6%
Cap/Sales(5y)1.96%
Profit Quality(3y)136%
Profit Quality(5y)132.69%
High Growth Momentum
Growth
EPS 1Y (TTM)36.07%
EPS 3Y23.81%
EPS 5Y42.98%
EPS Q2Q%-5.69%
EPS Next Y-8.19%
EPS Next 2Y-5.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y20.65%
Revenue growth 5Y17.51%
Sales Q2Q%0.17%
Revenue Next Year-1.53%
Revenue Next 2Y1.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.31%
FCF growth 3Y20.09%
FCF growth 5Y25.89%
OCF growth 1Y34.31%
OCF growth 3Y22.48%
OCF growth 5Y23.47%